Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CalciMedica, Inc. - Common Stock (NQ: CALC )

3.710 -0.250 (-6.31%)
Streaming Delayed Price Updated: 10:29 AM EDT, Jul 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CalciMedica, Inc. - Common Stock

CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024
CALC stock results show that CalciMedica beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Massively Undervalued 10-Bagger Stocks to Buy
Explore three massively undervalued stocks to buy, offering significant growth potential in the industrial and healthcare sectors. 
Via InvestorPlace
CalciMedica And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
CALC Stock Earnings: CalciMedica Reported Results for Q4 2023
CalciMedica just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Top 4 Health Care Stocks That May Crash This Quarter
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Gannett And 3 Other Stocks Under $4 Insiders Are Buying
The Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
From CalciMedica
Via GlobeNewswire
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
CalciMedica Announces Relisting on Nasdaq
From CalciMedica
Via GlobeNewswire
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
From CalciMedica
Via GlobeNewswire
CalciMedica Expands Executive Team with New Appointments
Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical Development 
From CalciMedica
Via GlobeNewswire
Houston American Energy And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed higher by over 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
From CalciMedica
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.